Bilcare Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 29, 2025, 7:55 pm

Quick Insight

Bilcare Ltd, a player in the Packaging & Containers industry, currently trades at a price of 64.6 with a market capitalization of 152 Cr. The company's financial indicators reveal a low ROE of 5.31% and a ROCE of 1.29%, indicating suboptimal efficiency in generating returns. With a negative Net Profit of -56 Cr, the firm faces profitability challenges. Moreover, its high level of borrowings at ₹682 Cr raises concerns about leverage and financial risk. The low P/BV ratio of 0.46x and weak Interest Coverage Ratio of 0.76x suggest undervaluation and potential solvency issues. Investors should closely monitor Bilcare's operational performance and debt management strategies to assess its sustainability in the market.

Competitors of Bilcare Ltd

All Competitor Stocks of Bilcare Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:42 am

Below is a detailed analysis of the quarterly data for Bilcare Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 194.03 Cr.. The value appears to be declining and may need further review. It has decreased from 198.13 Cr. (Dec 2024) to 194.03 Cr., marking a decrease of 4.10 Cr..
• For Expenses, as of Mar 2025, the value is 186.64 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 187.48 Cr. (Dec 2024) to 186.64 Cr., marking a decrease of 0.84 Cr..
• For Operating Profit, as of Mar 2025, the value is 7.39 Cr.. The value appears to be declining and may need further review. It has decreased from 10.65 Cr. (Dec 2024) to 7.39 Cr., marking a decrease of 3.26 Cr..
• For OPM %, as of Mar 2025, the value is 3.81%. The value appears to be declining and may need further review. It has decreased from 5.38% (Dec 2024) to 3.81%, marking a decrease of 1.57%.
• For Other Income, as of Mar 2025, the value is 21.16 Cr.. The value appears strong and on an upward trend. It has increased from -6.47 Cr. (Dec 2024) to 21.16 Cr., marking an increase of 27.63 Cr..
• For Interest, as of Mar 2025, the value is 18.49 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 19.48 Cr. (Dec 2024) to 18.49 Cr., marking a decrease of 0.99 Cr..
• For Depreciation, as of Mar 2025, the value is 11.58 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 11.74 Cr. (Dec 2024) to 11.58 Cr., marking a decrease of 0.16 Cr..
• For Profit before tax, as of Mar 2025, the value is -1.52 Cr.. The value appears strong and on an upward trend. It has increased from -27.04 Cr. (Dec 2024) to -1.52 Cr., marking an increase of 25.52 Cr..
• For Tax %, as of Mar 2025, the value is -431.58%. The value appears to be improving (decreasing) as expected. It has decreased from -39.90% (Dec 2024) to -431.58%, marking a decrease of 391.68%.
• For Net Profit, as of Mar 2025, the value is 5.04 Cr.. The value appears strong and on an upward trend. It has increased from -16.25 Cr. (Dec 2024) to 5.04 Cr., marking an increase of 21.29 Cr..
• For EPS in Rs, as of Mar 2025, the value is 4.48. The value appears strong and on an upward trend. It has increased from -3.05 (Dec 2024) to 4.48, marking an increase of 7.53.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:31 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:41 pm

Below is a detailed analysis of the balance sheet data for Bilcare Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 24.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 24.00 Cr..
• For Reserves, as of Mar 2025, the value is 445.00 Cr.. The value appears to be declining and may need further review. It has decreased from 474.00 Cr. (Mar 2024) to 445.00 Cr., marking a decrease of 29.00 Cr..
• For Borrowings, as of Mar 2025, the value is 682.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 756.00 Cr. (Mar 2024) to 682.00 Cr., marking a decrease of 74.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 266.00 Cr.. The value appears to be improving (decreasing). It has decreased from 314.00 Cr. (Mar 2024) to 266.00 Cr., marking a decrease of 48.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,417.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,568.00 Cr. (Mar 2024) to 1,417.00 Cr., marking a decrease of 151.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 950.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,038.00 Cr. (Mar 2024) to 950.00 Cr., marking a decrease of 88.00 Cr..
• For CWIP, as of Mar 2025, the value is 3.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2024) to 3.00 Cr., marking an increase of 2.00 Cr..
• For Investments, as of Mar 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2024) to 11.00 Cr., marking an increase of 3.00 Cr..
• For Other Assets, as of Mar 2025, the value is 453.00 Cr.. The value appears to be declining and may need further review. It has decreased from 521.00 Cr. (Mar 2024) to 453.00 Cr., marking a decrease of 68.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,417.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,568.00 Cr. (Mar 2024) to 1,417.00 Cr., marking a decrease of 151.00 Cr..

However, the Borrowings (682.00 Cr.) are higher than the Reserves (445.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Bilcare Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -12.22. This value is below the healthy minimum of 5. It has increased from -14.12 (Mar 24) to -12.22, marking an increase of 1.90.
• For Diluted EPS (Rs.), as of Mar 25, the value is -12.22. This value is below the healthy minimum of 5. It has increased from -14.12 (Mar 24) to -12.22, marking an increase of 1.90.
• For Cash EPS (Rs.), as of Mar 25, the value is -4.37. This value is below the healthy minimum of 3. It has increased from -5.77 (Mar 24) to -4.37, marking an increase of 1.40.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 199.17. It has decreased from 274.44 (Mar 24) to 199.17, marking a decrease of 75.27.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 199.17. It has decreased from 274.44 (Mar 24) to 199.17, marking a decrease of 75.27.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 334.62. It has increased from 317.34 (Mar 24) to 334.62, marking an increase of 17.28.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 26.79. This value is within the healthy range. It has increased from 26.19 (Mar 24) to 26.79, marking an increase of 0.60.
• For PBIT / Share (Rs.), as of Mar 25, the value is 7.31. This value is within the healthy range. It has increased from 7.10 (Mar 24) to 7.31, marking an increase of 0.21.
• For PBT / Share (Rs.), as of Mar 25, the value is -30.29. This value is below the healthy minimum of 0. It has increased from -30.45 (Mar 24) to -30.29, marking an increase of 0.16.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -23.85. This value is below the healthy minimum of 2. It has increased from -24.86 (Mar 24) to -23.85, marking an increase of 1.01.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -12.22. This value is below the healthy minimum of 2. It has increased from -14.12 (Mar 24) to -12.22, marking an increase of 1.90.
• For PBDIT Margin (%), as of Mar 25, the value is 8.00. This value is below the healthy minimum of 10. It has decreased from 8.25 (Mar 24) to 8.00, marking a decrease of 0.25.
• For PBIT Margin (%), as of Mar 25, the value is 2.18. This value is below the healthy minimum of 10. It has decreased from 2.23 (Mar 24) to 2.18, marking a decrease of 0.05.
• For PBT Margin (%), as of Mar 25, the value is -9.05. This value is below the healthy minimum of 10. It has increased from -9.59 (Mar 24) to -9.05, marking an increase of 0.54.
• For Net Profit Margin (%), as of Mar 25, the value is -7.12. This value is below the healthy minimum of 5. It has increased from -7.83 (Mar 24) to -7.12, marking an increase of 0.71.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -3.65. This value is below the healthy minimum of 8. It has increased from -4.44 (Mar 24) to -3.65, marking an increase of 0.79.
• For Return on Networth / Equity (%), as of Mar 25, the value is -6.13. This value is below the healthy minimum of 15. It has increased from -6.67 (Mar 24) to -6.13, marking an increase of 0.54.
• For Return on Capital Employeed (%), as of Mar 25, the value is 1.59. This value is below the healthy minimum of 10. It has increased from 1.37 (Mar 24) to 1.59, marking an increase of 0.22.
• For Return On Assets (%), as of Mar 25, the value is -2.03. This value is below the healthy minimum of 5. It has increased from -2.12 (Mar 24) to -2.03, marking an increase of 0.09.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.98. This value is within the healthy range. It has decreased from 1.09 (Mar 24) to 0.98, marking a decrease of 0.11.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.45. This value exceeds the healthy maximum of 1. It has decreased from 1.52 (Mar 24) to 1.45, marking a decrease of 0.07.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.52. It has increased from 0.47 (Mar 24) to 0.52, marking an increase of 0.05.
• For Current Ratio (X), as of Mar 25, the value is 1.01. This value is below the healthy minimum of 1.5. It has decreased from 1.17 (Mar 24) to 1.01, marking a decrease of 0.16.
• For Quick Ratio (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 1. It has decreased from 0.87 (Mar 24) to 0.66, marking a decrease of 0.21.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.80. This value is within the healthy range. It has decreased from 5.47 (Mar 24) to 4.80, marking a decrease of 0.67.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 3. It has increased from 0.75 (Mar 24) to 0.76, marking an increase of 0.01.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 3. It has increased from 0.36 (Mar 24) to 0.39, marking an increase of 0.03.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,004.36. It has increased from 998.83 (Mar 24) to 1,004.36, marking an increase of 5.53.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has decreased from 1.34 (Mar 24) to 1.27, marking a decrease of 0.07.
• For EV / EBITDA (X), as of Mar 25, the value is 15.92. This value exceeds the healthy maximum of 15. It has decreased from 16.20 (Mar 24) to 15.92, marking a decrease of 0.28.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has increased from 0.17 (Mar 24) to 0.27, marking an increase of 0.10.
• For Price / BV (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 1. It has increased from 0.26 (Mar 24) to 0.46, marking an increase of 0.20.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has increased from 0.17 (Mar 24) to 0.27, marking an increase of 0.10.
• For EarningsYield, as of Mar 25, the value is -0.13. This value is below the healthy minimum of 5. It has increased from -0.25 (Mar 24) to -0.13, marking an increase of 0.12.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness